Chester County News and Community Website
NEW HOPE, PA — Two groundbreaking presentations were announced at the recent Cardiovascular Research Technologies (CRT) 2024 Meeting by Orchestra BioMed Holdings Inc., a headline-grabbing revelation that left the industry …
Orchestra BioMed Lifts the Veil on Cutting-Edge Treatments at CRT 2024 Read More
BERWYN, PA — In a move to promote diversity in clinical trials, Chester County-based Mural Health has announced the “Harley Jacobsen Clinical Trial Participation Income Exemption Act,” a landmark legislation …
Mural Health Champions Revolutionary Bill for Enhanced Diversity in Clinical Trials Read More
MALVERN, PA — YPrime, a leading provider of electronic clinical outcomes assessment (eCOA) platforms, has released the results of a comprehensive survey examining the experiences and perspectives of clinical stakeholders …
YPrime Unveils Key Insights into eCOA Adoption and Concerns in Clinical Research Read More
MALVERN, PA — In a strategic move that underscores its nearly two-decade legacy of innovation in the clinical trial space, YPrime this week announced a comprehensive brand evolution initiative. The …
YPrime Unveils Bold Brand Evolution, Aiming to Streamline and Accelerate Clinical Trials Read More
BERWYN, PA — Mural Health, a company specializing in patient-first clinical trial technology, is spearheading an initiative to improve access to experimental treatments for millions of Americans on public assistance. …
Mural Health Advocates for Income Exclusion to Boost Clinical Trial Diversity and Access Read More
A new weight loss drug has been shown to be successful in a phase 3 clinical trial. Eli Lilly and Company’s (NYSE: LLY) tirzepatide was shown to result in weight …
New Drug Achieves Weight Loss in Adults with Obesity Read More